Covina, April 05, 2023 (GLOBE NEWSWIRE) -- Cephalosporin drugs are a class of antibiotics that are widely used in the treatment of bacterial infections. They are structurally similar to penicillin and have a broad spectrum of activity against a variety of gram-positive and gram-negative bacteria. They belong to a class beta-lactams and are a large group of antibiotics and they are used to prevent from a wide range of bacterial infections.
Wide applications of Cephalosporin Drugs for curing Respiratory Infections, Skin and Soft Tissue Infections, Urinary Tract Infections, Meningitis, Surgical Prophylaxis and Septicemia has become a key factor in target market growth. Rapid growth in urbanization and healthcare industry has further facilitated the demand for target market growth. Due to the increased frequency of infectious diseases like HIV and tuberculosis, rising need for anti-microbials for a variety of reasons and rising funding for the development of antibiotics is anticipated to expand market growth. Overall, Cephalosporin medications are used to treat a variety of bacterial infections, and their safe and effective profile make them an important tool in the toolbox of doctors and other healthcare professionals.
The report “Cephalosporin Drugs Market, By Generation (First Generation, Second Generation, Third Generation, Fourth Generation, and Fifth Generation), By Route of Administration (Injection and Oral), By Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”
Key Highlights:
- In November 2019, the US Food and Drug Administration (FDA) approved a new “Cefiderocol” for the treatment of complicated urinary tract infections (cUTI) which includes pyelonephritis that is caused by susceptible Gram-negative bacteria. Cefiderocol does not require a BLI to protect it from hydrolysis by ß-lactamases and is the first new cephalosporin.
- In June 2019, Merk & Co. announced that FDA approved its supplemental New Drug Application for the use of “ZERBAXA” for the treatment of 18 years and older patients with hospital acquired bacterial pneumonia and ventilator associated bacterial pneumonia.
Request Free Sample:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2923
Scope of the Report:
- Market Preview
-
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
-
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Cephalosporin Drugs Market, By Product, 2022 – 2032, (US$ Bn)
-
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Polyster
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Nylon
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Polypropylene
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Carbon Fibers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- p-Aramid Fibers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- UHMWPE
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Cephalosporin Drugs Market, By Application, 2022 – 2032, (US$ Bn)
-
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Automotive
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Sporting Goods
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Industrial
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Military
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
Analyst View:
The key factor driving the growth of the Cephalosporin Drugs market increasing prevalence of bacterial infections worldwide. The rise of antibiotic-resistant bacteria has further complicated the treatment of bacterial infections, leading to an increased demand for more effective antibiotics. Increasing prevalence of bacterial infections, coupled with the rise of antibiotic-resistant bacteria, has led to an increased demand for cephalosporin drugs. This is expected to drive the growth of the Cephalosporin Drugs market in the coming years. Furthermore, the development of new and more effective cephalosporin drugs, along with favorable regulatory policies and advancements in manufacturing technologies, is expected to fuel the growth of the market.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Webbing-Market-By-Product-1485
Key Market Insights from the report:
Cephalosporin Drugs Market accounted for US$ 18.7 billion in 2022 and is estimated to be US$ 24.4 billion by 2032 and is anticipated to register a CAGR of 2.5%. The Cephalosporin Drugs Market is segmented based on Product, Application and Region.
- Based on Product, Cephalosporin Drugs Market is segmented into Polyester, Nylon, Polypropylene, Carbon Fibers, p-Aramid Fibers, UHMWPE, and Others.
- Based on Application, Cephalosporin Drugs Market is segmented into Automotive, Sporting Goods, Industrial, Military, and Others.
- By Region, the Cephalosporin Drugs Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Cephalosporin Drugs Market:
- Oppermann GmbH
- American Cord & Cephalosporin Drugs Co
- Belt-tech Products
- Narrowtex Australia Pty Ltd
- National Cephalosporin Drugs Products
- Murdock Cephalosporin Drugs Company
- Bally Ribbon Mills
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Other related reports:
- Facial Injectables Market: By Product Type (Dermal Fillers (Hyaluronic Acid Fillers, Collagen Fillers, and Synthetic Fillers), Anti-wrinkle Injection (Botulinum Toxin A, and Poly-L-lactic Acid (PLLA))), By Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others), By End User (Hospitals, Dermatology Centers, Beauty Clinics, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029
- Scopolamine Market: By Dosage Form (Oral, Tablets, Transdermal Patches, Injections, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029
- Ranitidine Market: By Strength (75 mg, 150 mg, and 300 mg), By Indication (Intestinal& Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, and Others), By Dosage Form (Tablets, Syrups, and Injections), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital pharmacies, Retail Pharmacies, and Online Pharmacies) and Region - Trends, Analysis and Forecast till 2030
